Evaluation of Efficacy of Bee Pollen in the Treatment of Oral Submucous Fibrosis Patients: A Randomized Clinical Drug Trial

Background: Oral submucous fibrosis (OSMF) is a rampant premalignant condition, and consumption of 'areca nut' has significant evidence in its etiology. Antioxidant supplementation provides the basis of chemoprevention, and therefore, nutraceutical products have taken an important position...

Full description

Bibliographic Details
Main Authors: Apeksha Dhole, Divya Dube, Mukta Motwani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Indian Academy of Oral Medicine and Radiology
Subjects:
Online Access:http://www.jiaomr.in/article.asp?issn=0972-1363;year=2023;volume=35;issue=3;spage=310;epage=314;aulast=Dhole
_version_ 1797645649311694848
author Apeksha Dhole
Divya Dube
Mukta Motwani
author_facet Apeksha Dhole
Divya Dube
Mukta Motwani
author_sort Apeksha Dhole
collection DOAJ
description Background: Oral submucous fibrosis (OSMF) is a rampant premalignant condition, and consumption of 'areca nut' has significant evidence in its etiology. Antioxidant supplementation provides the basis of chemoprevention, and therefore, nutraceutical products have taken an important position in the management of OSMF. Objectives: Evaluation of the efficacy of bee pollen in the management of OSMF. Method: This was a single-blinded randomized controlled drug trial. There were two groups: group A/study group was administered with bee pollen capsules, and Group B/control group was given lycopene group. Along with this, both the groups were administered multi-vitamin tablets. Both the groups were further divided into three sub-groups of OSMF. All patients were evaluated for 3 months in every 15 days for burning sensation, cheek flexibility, tongue protrusion, mouth opening, blanching, and fibrous bands. Results: A statistically significant increase in cheek flexibility, tongue protrusion, and mouth opening and improvement in burning were seen in all three grades of OSMF in both groups. Conclusion: The administration of bee pollen is safe and can be accounted as an adjuvant in patients with OSMF.
first_indexed 2024-03-11T14:49:52Z
format Article
id doaj.art-84a6a76184954bcca80f989c9cb424c0
institution Directory Open Access Journal
issn 0972-1363
language English
last_indexed 2024-03-11T14:49:52Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Indian Academy of Oral Medicine and Radiology
spelling doaj.art-84a6a76184954bcca80f989c9cb424c02023-10-30T10:03:33ZengWolters Kluwer Medknow PublicationsJournal of Indian Academy of Oral Medicine and Radiology0972-13632023-01-0135331031410.4103/jiaomr.jiaomr_86_23Evaluation of Efficacy of Bee Pollen in the Treatment of Oral Submucous Fibrosis Patients: A Randomized Clinical Drug TrialApeksha DholeDivya DubeMukta MotwaniBackground: Oral submucous fibrosis (OSMF) is a rampant premalignant condition, and consumption of 'areca nut' has significant evidence in its etiology. Antioxidant supplementation provides the basis of chemoprevention, and therefore, nutraceutical products have taken an important position in the management of OSMF. Objectives: Evaluation of the efficacy of bee pollen in the management of OSMF. Method: This was a single-blinded randomized controlled drug trial. There were two groups: group A/study group was administered with bee pollen capsules, and Group B/control group was given lycopene group. Along with this, both the groups were administered multi-vitamin tablets. Both the groups were further divided into three sub-groups of OSMF. All patients were evaluated for 3 months in every 15 days for burning sensation, cheek flexibility, tongue protrusion, mouth opening, blanching, and fibrous bands. Results: A statistically significant increase in cheek flexibility, tongue protrusion, and mouth opening and improvement in burning were seen in all three grades of OSMF in both groups. Conclusion: The administration of bee pollen is safe and can be accounted as an adjuvant in patients with OSMF.http://www.jiaomr.in/article.asp?issn=0972-1363;year=2023;volume=35;issue=3;spage=310;epage=314;aulast=Dholeantioxidantsbee pollennutraceutical agentoral submucous fibrosis
spellingShingle Apeksha Dhole
Divya Dube
Mukta Motwani
Evaluation of Efficacy of Bee Pollen in the Treatment of Oral Submucous Fibrosis Patients: A Randomized Clinical Drug Trial
Journal of Indian Academy of Oral Medicine and Radiology
antioxidants
bee pollen
nutraceutical agent
oral submucous fibrosis
title Evaluation of Efficacy of Bee Pollen in the Treatment of Oral Submucous Fibrosis Patients: A Randomized Clinical Drug Trial
title_full Evaluation of Efficacy of Bee Pollen in the Treatment of Oral Submucous Fibrosis Patients: A Randomized Clinical Drug Trial
title_fullStr Evaluation of Efficacy of Bee Pollen in the Treatment of Oral Submucous Fibrosis Patients: A Randomized Clinical Drug Trial
title_full_unstemmed Evaluation of Efficacy of Bee Pollen in the Treatment of Oral Submucous Fibrosis Patients: A Randomized Clinical Drug Trial
title_short Evaluation of Efficacy of Bee Pollen in the Treatment of Oral Submucous Fibrosis Patients: A Randomized Clinical Drug Trial
title_sort evaluation of efficacy of bee pollen in the treatment of oral submucous fibrosis patients a randomized clinical drug trial
topic antioxidants
bee pollen
nutraceutical agent
oral submucous fibrosis
url http://www.jiaomr.in/article.asp?issn=0972-1363;year=2023;volume=35;issue=3;spage=310;epage=314;aulast=Dhole
work_keys_str_mv AT apekshadhole evaluationofefficacyofbeepolleninthetreatmentoforalsubmucousfibrosispatientsarandomizedclinicaldrugtrial
AT divyadube evaluationofefficacyofbeepolleninthetreatmentoforalsubmucousfibrosispatientsarandomizedclinicaldrugtrial
AT muktamotwani evaluationofefficacyofbeepolleninthetreatmentoforalsubmucousfibrosispatientsarandomizedclinicaldrugtrial